Osnabrugge RL, Mylotte D, HeadSJ, VanMieghemNM,NkomoVT, LeReunCMet al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013;62:1002-12.
DweckMR, Jones C, JoshiNV, Fletcher AM,Richardson H, WhiteAet al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012;125:76-86.
Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-70.
Cioffi G, Faggiano P, Vizzardi E, Tarantini L, Cramariuc D, Gerdts E et al. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart 2011;97:301-7.
HerrmannS, Stork S, Niemann M, LangeV, Strotmann JM, Frantz S et al. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. J Am Coll Cardiol 2011;58:402-12.
Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000;102:1388-93.
Dalsgaard M, Iversen K, Kjaergaard J, Grande P, Goetze JP, Clemmensen P et al. Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study. Am Heart J 2014;167:226-34.
Nadir MA, Wei L, Elder DH, Libianto R, Lim TK, Pauriah M et al. Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol 2011;58:570-6.
Cote N, Pibarot P, Pepin A, Fournier D, Audet A, Arsenault B et al. Oxidized lowdensity lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis. Int J Cardiol 2010;145:444-9.
O'BrienKD, Shavelle DM,CaulfieldMT,McDonald TO, Olin-Lewis K, OttoCMet al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002;106:2224-30.
Helske S, Lindstedt KA, Laine M, Mayranpaa M,Werkkala K, Lommi J et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol 2004;44:1859-66.
Capoulade R, Clavel MA, Mathieu P, Cote N, Dumesnil JG, ArsenaultMet al. Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis. Eur J Clin Invest 2013;43:1262-72.
Rosenhek R, Rader F, Loho N, Gabriel H, Heger M, Klaar U et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004;110:1291-5.
Bull S, Loudon M, Francis J, Joseph J, Gerry S. A prospective, double-blind, randomised controlled trial of the angiotensin converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial). Eur Heart J Cardiovasc Imaging 2015; doi:10.1093/ehjci/jev043.
